To identify clinical incidence, risk factors and treatment of peripherally inserted central venous catheters (PICCs)-related upper extremity venous thrombosis (UEVT) in breast cancer patients undergoing chemotherapy.
Methods
We performed a retrospective cohort study of breast cancer patients with PICC insertion undergoing chemotherapy. PICC-related UEVT was diagnosed by ultrasound. Patient-, catheter- and insertion-related factors were analyzed in univariable and multivariable logistic regression to identify significant independent risk factors for PICC-related UEVT. The incidence and treatment of PICC-related UEVT were also analyzed.
Results
A total of 568 breast cancer patients with PICC undergoing chemotherapy were included, for a total of 54,769 catheter days; 8 patients (1.4%) developed PICC-related UEVT. The median time of developing UEVT was 11 days (range of 3 to 79 days). In multivariable analysis, metastasis (p = 0.002) and malposition (p = 0.013) were shown to be significant risk factors for PICC-related UEVT. All patients were treated with low-molecular-weight heparin (LMWH) and followed until PICCs were removed. None of the patients developed pulmonary embolus.
Conclusions
Metastasis and malposition were significant risk factors for PICC-related UEVT in breast cancer patients. With early diagnosis and standardized anticoagulant treatment, a better clinical outcome could be achieved. Further prospective and large sample studies are needed.
ChopraVRatzDKuhnLLopusTLeeAKreinSPeripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors.J Thromb Haemost2014;12(6):847–854
2.
EvansRSSharpJHLinfordLHet al.Reduction of peripherally inserted central catheter-associated DVT.Chest2013;143(3):627–633
3.
CoadyKAliMSidloffDKenninghamRRAhmedSA comparison of infections and complications in central venous catheters in adults with solid tumours.J Vasc Access2015;16(1):38–41
4.
ChopraVAnandSHicknerAet al.Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.Lancet2013;382(9889):311–325
5.
EvansRSSharpJHLinfordLHet al.Risk of symptomatic DVT associated with peripherally inserted central catheters.Chest2010;138(4):803–810
6.
AwACarrierMKoczerginskiJMcDiarmidSTayJIncidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients.Thromb Res2012;130(3):323–326
7.
WilsonTJBrownDLMeurerWJStetlerWRJrWilkinsonDAFletcherJJRisk factors associated with peripherally inserted central venous catheter-related large vein thrombosis in neurological intensive care patients.Intensive Care Med2012;38(2):272–278
8.
TranHArellanoMChamsuddinAet al.Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters.Leuk Lymphoma2010;51(8):1473–1477
9.
BonizzoliMBatacchiSCianchiGet al.Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients.Intensive Care Med2011;37(2):284–289
10.
ZochiosVUmarISimpsonNJonesNPeripherally inserted central catheter (PICC)-related thrombosis in critically ill patients.J Vasc Access2014;15(5):329–337
11.
MarnejonTAngeloDAbu AbdouAGemmelDRisk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters.J Vasc Access2012;13(2):231–238
12.
TranBHNguyenTJHwangBHet al.Risk factors associated with venous thromboembolism in 49,028 mastectomy patients.Breast2013;22(4):444–448
13.
SperryBWRoskosMOskouiRThe effect of laterality on venous thromboembolism formation after peripherally inserted central catheter placement.J Vasc Access2012;13(1):91–95
14.
PettersonTMMarksRSAshraniAABaileyKRHeitJARisk of site-specific cancer in incident venous thromboembolism: a population-based study.Thromb Res2015;135(3):472–478
15.
YapYSKarapetisCLeroseSIyerSKoczwaraBReducing the risk of peripherally inserted central catheter line complications in the oncology setting.Eur J Cancer Care (Engl)2006;15(4):342–347
16.
LeeAYKamphuisenPWEpidemiology and prevention of catheter-related thrombosis in patients with cancer.J Thromb Haemost2012;10(8):1491–1499
17.
SaberWMouaTWilliamsECet al.Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies.J Thromb Haemost2011;9(2):312–319
18.
VersoMAgnelliGKamphuisenPWet al.Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients.Intern Emerg Med2008;3(2):117–122
19.
VersoMGussoniGAgnelliGPrevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studies.J Thromb Haemost2010;8(7):1649–1651
20.
AmerasekeraSSJonesCMPatelRCleasbyMJImaging of the complications of peripherally inserted central venous catheters.Clin Radiol2009;64(8):832–840
21.
LoboBLVaideanGBroylesJReavesABShorrRIRisk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters.J Hosp Med2009;4(7):417–422
22.
LiemTKYanitKEMoseleySEet al.Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis.J Vasc Surg2012;55(3):761–767
23.
PiranSNgoVMcDiarmidSLe GalGPetrcichWCarrierMIncidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.Thromb Res2014;133(1):30–33
24.
LinJWakefieldTWHenkePKRisk factors associated with venous thromboembolic events in patients with malignancy.Blood Coagul Fibrinolysis2006;17(4):265–270
25.
TesselaarMEOuwerkerkJNooyMARosendaalFROsantoSRisk factors for catheter-related thrombosis in cancer patients.Eur J Cancer2004;40(15):2253–2259
26.
BaarslagHJvan BeekEJKoopmanMMReekersJAProspective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities.Ann Intern Med2002;136(12):865–872
27.
GuyattGHAklEACrowtherMet al.Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest2012;142(2 Suppl):7S–47S
28.
KovacsMJKahnSRRodgerMet al.A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study).J Thromb Haemost2007;5(8):1650–1653
29.
FaustinoEVSpinellaPCLiSet al.Incidence and acute complications of asymptomatic central venous catheter-related deep venous thrombosis in critically ill children.J Pediatr2013;162(2):387–391
30.
DebourdeauPFargeDBeckersMet al.International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.J Thromb Haemost2013;11(1):71–80
31.
MasoomiHPaydarKZWirthGAAlyAKobayashiMREvansGRPredictive risk factors of venous thromboembolism in autologous breast reconstruction surgery.Ann Plast Surg2014;72(1):30–33
